---
title: "Tenax rises on over $1.8M insider buying"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296908250.md"
description: "Tenax Therapeutics (TENX) shares rose nearly 13% in premarket trading after Adar1 Capital Management, a key shareholder holding over 10%, purchased more than $1.8 million worth of stock. The investment manager bought over 1 million shares at an average price of $1.77, increasing its stake by roughly 27%. This purchase follows a recent setback where Tenax lost nearly 90% of its value due to trial issues with its lead asset, TNX-103. Despite this, Wall Street analysts remain bullish, maintaining seven Buy ratings."
datetime: "2026-08-25T11:45:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296908250.md)
  - [en](https://longbridge.com/en/news/296908250.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296908250.md)
generator: "portal-rs"
---

# Tenax rises on over $1.8M insider buying


### Related Stocks

- [TENX.US](https://longbridge.com/en/quote/TENX.US.md)

## Related News & Research

- [Tenax Therapeutics CEO to present at Cantor Global Healthcare Conference](https://longbridge.com/en/news/297640837.md)
- [Tenax presents Phase 3 LEVEL data showing TNX-103 boosts 6-minute walk distance in lower baseline subgroup](https://longbridge.com/en/news/297402619.md)
- [Trifork chair Anja Monrad buys shares worth DKK 1.00 million](https://longbridge.com/en/news/297066891.md)
- [REG - PetroTal Corp. - Director Dealing](https://longbridge.com/en/news/297051700.md)
- [Clinton Roeder Buys Handful Of Shares In Team](https://longbridge.com/en/news/297185240.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**